Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

被引:22
|
作者
Li, Di [1 ,2 ,5 ,6 ]
Deng, Chaoqiang [1 ,2 ,5 ,6 ]
Wang, Shengping [4 ,5 ,6 ]
Li, Yuan [3 ,5 ,6 ]
Zhang, Yang [1 ,2 ,5 ,6 ]
Chen, Haiquan [1 ,2 ,5 ,6 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Thorac Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, State Key Lab Genet Engn, Shanghai, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 200032, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Inst Thorac Oncol, Shanghai, Peoples R China
[6] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
adenocarcinoma in situ; minimally invasive adenocarcinoma; prognosis; secondary primary lung cancer; sublobar resection; SECTION COMPUTED-TOMOGRAPHY; LIMITED-RESECTION; IASLC/ATS/ERS CLASSIFICATION; RANDOMIZED-TRIAL; LOBECTOMY; DIAGNOSIS; OUTCOMES; IMPACT; TUMORS;
D O I
10.1016/j.jtcvs.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods: Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results: After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10- year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1%(41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions: Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
引用
收藏
页码:1614 / +
页数:10
相关论文
共 50 条
  • [1] Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer
    Li, Xiongfei
    Fan, Fanfan
    Yang, Zijiang
    Huang, Qingyuan
    Fu, Fangqiu
    Zhang, Yang
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (09) : 5729 - 5737
  • [2] Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung
    Yotsukura, Masaya
    Asamura, Hisao
    Motoi, Noriko
    Kashima, Jumpei
    Yoshida, Yukihiro
    Nakagawa, Kazuo
    Shiraishi, Kouya
    Kohno, Takashi
    Yatabe, Yasushi
    Watanabe, Shun-ichi
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) : 1312 - 1320
  • [3] Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer
    Niimi, Takahiro
    Samejima, Joji
    Wakabayashi, Masashi
    Miyoshi, Tomohiro
    Tane, Kenta
    Aokage, Keiju
    Taki, Tetsuro
    Nakai, Tokiko
    Ishii, Genichiro
    Kikuchi, Akitomo
    Yoshioka, Emi
    Yokose, Tomoyuki
    Ito, Hiroyuki
    Tsuboi, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (04) : 479 - 488
  • [4] Wedge Resection Is Enough for Curing GGO Patients with Minimally Invasive Adenocarcinoma (MIA) of the Lung?
    Zhang, J.
    Chen, N.
    Qiu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2409 - S2409
  • [5] Curative resection of colorectal adenocarcinoma: Multivariate analysis of 5-year follow-up
    Chen, HS
    WORLD JOURNAL OF SURGERY, 1999, 23 (12) : 1301 - 1306
  • [6] Curative Resection of Colorectal Adenocarcinoma: Multivariate Analysis of 5-Year Follow-up
    Chen Han-Shiang
    World Journal of Surgery, 1999, 23 : 1301 - 1306
  • [7] Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients
    Meng Jia
    Shili Yu
    Lanqing Cao
    Ping-Li Sun
    Hongwen Gao
    Annals of Surgical Oncology, 2020, 27 : 3052 - 3063
  • [8] Clinicopathologic Features and Genetic Alterations in Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung: Long-Term Follow-Up Study of 121 Asian Patients
    Jia, Meng
    Yu, Shili
    Cao, Lanqing
    Sun, Ping-Li
    Gao, Hongwen
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 3052 - 3063
  • [9] Mutational distinction between adenocarcinoma in situ, minimally invasive adenocarcinoma and invasive adenocarcinoma in lung cancer patients with multiple tumors.
    Liu, Jixian
    Li, Yingmei
    Xie, Yuancai
    Luan, Xinyu
    Peng, Xuxing
    Mu, Tianhao
    Chen, Shifu
    Wu, Da
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Lung cancer survival with herbal medicine and vitamins: Ten-year follow-up
    McCulloch, M. F.
    Broffman, M.
    van der Laan, M.
    Hubbard, A.
    Kushi, L.
    Kramer, A. M.
    Gao, J.
    Colford, J. M., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)